Search Results - "Powe, D.G"

Nonallergic Rhinitis-Identifying Gaps in Research by Esteitie, R, Jones, N.S, Toskala, E, Cruz, A.A., MD, Powe, D.G, Naclerio, R, Shusterman, D.J, Lieberman, P, Baraniuk, J.N, Mullol, J, Baroody, F.M, Wagenmann, M, White, M, Scadding, G, Settipane, R, Fokkens, W, Pawankar, R, Togias, A

“…Pathophysiology research covered areas of nasal hyperreactivity and autonomic nerve dysfunction, but the evidence was inconclusive. The presence of mucosal…”
Get full text

O-17 Borderline HER2 protein positive breast cancers have similar patient outcome regardless of HER2 gene amplification status by Barros, F.F.T, Aleskandarany, M, Rakha, E, Watts, S.L, Powe, D.G, Ellis, I.O, Green, A.R

Get full text

O-37 SOX11 and PSMD3 expression in HER2 positive breast cancer by Pang, Y, Ball, G.R, Rakha, E.A, Powe, D.G, Caldas, C, Ellis, I.O, Green, A.R

Get full text

445 Beta-blocker treatment is associated with a reduction in tumour metastasis and an improvement in specific survival in patients with breast cancer by Powe, D.G, Voss, M.J, Habashy, H.O, Zänker, K.S, Green, A.R, Ellis, I.O, Entschladen, F

Get full text

112 Luminal-like oestrogen receptor-positive breast cancer: identification of prognostic biological subclasses by Habashy, H.O, Powe, D.G, Ball, G, Glaab, E, Soria, D, Garibaldi, J, Krasnogor, N, Green, A.R, Caldas, C, Ellis, I.O

Get full text

125 Beta-blockers inhibit tumour cell migration: a potential use as anti-metastatic drugs by Entschladen, F, Voss, M.J, Zänker, K.S, Niggemann, B, Palm, D, Habashy, H.O, Ellis, I.O, Powe, D.G

Get full text

5015 The need for a biological grading system and its relationship to the current Nottingham histological grading system (NGS) by Abdel-Fatah, T.M.A, Powe, D.G, Ball, G, Reis-Filho, J.S, Ellis, I.O

Get full text

5030 High resolution array Comparative Genomic Hybridization (aCGH) of breast carcinoma identifies Mouse double minutes 4 (Mdm4) as one of the early genetic changes in breast cancer development – Mdm4 is a new independent prognostic and predictive marker by Abdel-Fatah, T.M.A, Powe, D.G, Lambros, M, Reis-Filho, J.S, Ellis, I.O

Get full text

O-88 Breast cancer among Nigerian women: Clinical and biological differences compared with age-matched UK women by Agboola, J, Banjo, A.A, Wanangwa, N, El-Sheikh, S, Rakha, E.A, Paish, E.C, Watts, S, Powe, D.G, Ellis, I.O, Green, A.R

Get full text

5175 Columnar cell lesions are the early precursors of some forms of invasive breast carcinoma – a new genetic map for the evolutionary pathway of low nuclear grade breast neoplasia (LNGBN) family by Abdel-Fatah, T.M.A, Powe, D.G, Lambros, M, De Biase, D, Savage, K, Mackay, A, Reis-Filho, J.S, Ellis, I.O

Get full text

Identification of key breast cancer phenotypes by Green, A, Garibaldi, J.M, Soria, D, Ambrogi, F, Powe, D.G, Ball, G, Lisboa, P.J.G, Boracchi, P, Biganzoli, E, Ellis, I.O

Get full text

O-39 Morphological and molecular evolutionary pathways of low and high grade breast cancers and theier putative precursor lesions by Abdel-Fatah, T, Powe, D.G, Hodi, Z, Reis-Filho, J.S, Lee, A, Ellis, I

Get full text

O-93 ALCAM is an independent predictor of survival in unselected breast cancer by Murali-Ganesh, R, Powe, D.G, Pancholi, A, Ball, G.R, Rakha, E, Ellis, I.O

Get full text

O-95 TOPO II is an independent predictor of survival in unselected breast cancer by Pancholi, A, Powe, D.G, Ganesh, R.M, Lambros, M, Reis-Filho, J.S, Rakha, E, Ellis, I.O

Get full text

Cytoplasmic PML promotes TGF-β-associated epithelial–mesenchymal transition and invasion in prostate cancer by Buczek, M E, Miles, A K, Green, W, Johnson, C, Boocock, D J, Pockley, A G, Rees, R C, Hulman, G, van Schalkwyk, G, Parkinson, R, Hulman, J, Powe, D G, Regad, T

“…Epithelial–mesenchymal transition (EMT) is a key event that is involved in the invasion and dissemination of cancer cells. Although typically considered as…”
Get full text

Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study by McCourt, C., Coleman, H.G., Murray, L.J., Cantwell, M.M., Dolan, O., Powe, D.G., Cardwell, C.R.

“…Summary Background Beta‐blockers have potential antiangiogenic and antimigratory activity. Studies have demonstrated a survival benefit in patients with…”
Get full text

β-Blocker usage and colorectal cancer mortality: a nested case–control study in the UK Clinical Practice Research Datalink cohort by Hicks, B.M., Murray, L.J., Powe, D.G., Hughes, C.M., Cardwell, C.R.

“…Epidemiological and laboratory studies suggest that β-blockers may reduce cancer progression in various cancer sites. The aim of this study was to conduct the…”
Get full text

Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study by Powe, D. G., Voss, M. J., Habashy, H. O., Zänker, K. S., Green, A. R., Ellis, I. O., Entschladen, F.

“…Breast cancer mortality is frequently associated with metastatic disease. Metastasis models have shown adrenoceptor (AR) stimulation induces cell migration…”
Get full text

proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer by Zhang, H, Rakha, E. A, Ball, G. R, Spiteri, I, Aleskandarany, M, Paish, E. C, Powe, D. G, Macmillan, R. D, Caldas, C, Ellis, I. O, Green, A. R

“…The basal-like or basal phenotype (BP) class of breast cancers have recently attracted attention as a poor prognostic form of breast cancer. However, BP…”
Get full text

validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks by Lancashire, L. J, Powe, D. G, Reis-Filho, J. S, Rakha, E, Lemetre, C, Weigelt, B, Abdel-Fatah, T. M, Green, A. R, Mukta, R, Blamey, R, Paish, E. C, Rees, R. C, Ellis, I. O, Ball, G. R

“…Gene expression microarrays allow for the high throughput analysis of huge numbers of gene transcripts and this technology has been widely applied to the…”
Get full text